Argireline

What is Argireline?

human RCT

Argireline is the trade name of a short synthetic peptide used in anti-ageing creams and serums. It was built for one job: the 2002 paper that introduced it says it was identified as a result of a rational design programme, aimed at non-toxic molecules that mimic the action of botulinum toxin1. Its sequence copies part of a nerve protein, and a 2013 trial describes it as patterned from the N-terminal end of the protein SNAP-252, one of the proteins a nerve uses to release its chemical signal. On a cosmetics label it sounds far more modest. A 2025 expert panel on cosmetic ingredient safety records its function in cosmetics as a skin conditioning agent3, which is the category a moisturiser falls into, not a muscle relaxant. That gap, between what it was designed to do and what it is formally sold as, runs through everything else on this page. Most of what follows concerns whether the design functions on a living face, and how rigorously anyone has been able to test it.

Is acetyl hexapeptide-8 the same as Argireline?

in vitro

Yes, and acetyl hexapeptide-3 is the same molecule under an older name. A 2024 analysis of search trends describes acetyl hexapeptide-8 as also known as Argireline4, while a 2014 study of skin delivery lists Argireline as acetyl hexapeptide-3, with a molecular weight of 889 Da5. The sequence settles it. A 2014 microneedle study writes acetyl hexapeptide-3 as AC-Glu-Glu-Met-Gln-Arg-Arg-NH26, and a 2015 skin study writes acetyl hexapeptide-8 as Ac-EEMQRR-amide7, which is the same six amino acids written in a shorter code. The 2025 safety panel also treats the amide form as synonymous with plain acetyl hexapeptide-83. So a label carrying any of these names is describing one ingredient, and the studies on this page can be read together whichever name they use. What a label cannot tell you is how much of the peptide is in the jar, or what condition it is in, and both of those matter for reasons that come up further down.

What does Argireline peptide do?

human RCT

In theory, it relaxes the small facial muscles that crease the skin during expression. The 2002 paper traced its effect to interference with the formation and/or stability of the protein complex a nerve needs to release its signal1. A 2013 eyelid-spasm trial calls it a competitive SNAP25 inhibitor8, meaning it competes with the real protein for a place in that complex, so the nerve's message gets through less well. The laboratory evidence that it does this is real, but it sits in dishes of cells. In nerve cells grown from human dental pulp stem cells, a 2018 study tested it by measuring the inhibition of glutamate release from the neurons in vitro9, and a 2025 skin-spheroid model, a small ball of grown skin cells with nerves, found the peptide suppressed acetylcholine release10, acetylcholine being the signal that tells a muscle to contract. A 2021 lab-grown human muscle model tested a version sold as Argireline Amplified, described there as a cosmetic ingredient that causes muscle relaxation11. All of this demonstrates the peptide can act on its target when positioned directly beside it. Whether a facial cream delivers it to a muscle is a separate question, and it is the one that determines everything else.

Does Argireline get through the skin?

in vitro

Not far, on most measurements, and every result depends on this question. A 2015 formulation study opened by noting that its skin penetration is sparsely studied and controversially discussed12. A 2025 review explains the obstacle: because of its hydrophilic nature and relatively large molecular size, it passes poorly through the fatty outer layer of the skin13. A 2018 study adds that it exists in zwitterionic form, carrying a positive and a negative charge at once, and that this charged state hindered its skin permeation9.

The direct measurements point the same way. In a 2015 test on both animal and donated human skin, the share held in the outer layer of hairless guinea pig skin was 0.54%7, and no peptide turned up in the fluid collected underneath the skin of either species7. One newer result points the other way: a 2025 study reported that ex vivo human skin studies confirmed the peptide can traverse the stratum corneum and accumulate in deeper layers10, though that work tested its own film rather than an ordinary cream. The figures for human skin from the 2015 study are set out on the peptides-for-skin overview. Read together, these indicate penetration depends on the formulation carrying the peptide, and a plain cream sits at the poor end.

Can anything help Argireline get deeper?

animal model

Yes, in laboratory and animal skin, and much of the recent work on this peptide is about exactly that. A 2015 study found a multiple water-in-oil-in-water emulsion can significantly increase penetration into porcine skin compared to simple emulsions12. Passing a weak electric current through the skin, a method called iontophoresis, led up to a 30 times increase in peptide permeation in a 2014 study5. In donated facial skin from Korean women aged 50 to 70, a 2026 study that paired microneedling with a cooling device raised the peptide's fluorescent signal by 1272%14. In pig skin, dissolving microneedles delivered 11.29% of the peptide, more than a plain solution of it15, and in a 2024 study, tiny plant-derived carriers called exosomes took it down to the dermis in tissue slices16. Every one of these is a delivery experiment, not a wrinkle trial. They show the skin barrier can be got around; they do not show that the peptide which then arrives relaxes a muscle in a person. They also change the exposure, a point the safety page picks up.

How has Argireline been applied in studies?

human RCT

Almost always as a cream or serum spread on the skin, usually around the eyes. In the 2013 placebo-controlled trial in Chinese subjects, the cream or placebo was applied to peri-orbital wrinkles twice daily for 4 weeks2. The strength varies a great deal between studies. A 2020 retrospective report used a gel-cream containing 10% acetyl hexapeptide-817, while a 2025 zebrafish study used an oil solution containing 0.125%18. Some work has gone beneath the skin. A 2023 surgical paper soaked polydioxanone (PDO) threads, used in a facial lifting protocol, in the peptide and measured its sustained release for 1 h19, and a 2026 rat study gave it by injection, with subdermal injections administered at six points20. Injection takes it well outside the cosmetic use it was designed for, and the one human report of it is covered on the Argireline safety page. The strengths above describe what studies used, not what anyone should apply.

Has Argireline been tested in people?

human RCT

Yes, in a handful of small trials, and their conclusions conflict. The largest randomised trial, from 2013, gave 60 subjects argireline or placebo in a ratio of 3:12, meaning about 45 people used the peptide and 15 used the placebo. A 2017 four-arm trial randomised 24 healthy volunteers21, and a 2013 trial tested daily topical application in 24 patients with blepharospasm, an involuntary eyelid spasm8. The first two reported an anti-wrinkle effect221. A 2023 study then recruited 19 women from a plastic surgery clinic, put the same serum on both sides of each face with the peptide on one side only, and concluded that the effect of Argireline was not proven22. That design, one face with and without the peptide, is the cleanest test of whether the peptide itself does anything, and it found nothing significant. None of these ran longer than a few months, and the biggest put about 45 people on the active cream. What each trial measured, outcome by outcome, is on the Argireline benefits page.

Why is Argireline called Botox in a bottle?

primary research

Because it was designed to imitate Botox, and people apply it at home without a needle. A 2024 analysis of Google searches in the United States found that the terms Argireline and Botox in a Bottle both rose sharply in 20224, although Argireline was still searched far less than Botox4. Its authors suggested the interest may come from its cost-effectiveness and its use as a botulinum neurotoxin alternative4. The phrase has reached the scientific literature too: a 2021 chemistry paper put Needle-Free Botox in its title23. The nickname describes an intention, not a measured equivalence between the two. How they actually compare, in how they are given, how they work and how much evidence stands behind each, is laid out on the Argireline comparison page.

What else has Argireline been tried for?

registered trial

Beyond wrinkles, the main medical use tested is blepharospasm, a condition in which the eyelids clamp shut on their own. A 2015 formulation paper notes it was recently explored as a promising topical treatment of blepharospasm12. Two registered trials exist for that use. One, a Phase 1/2 study of acetyl hexapeptide-8 in blepharospasm, is listed as completed24, with 24 people enrolled, the same size as the published 2013 pilot. The other, a Phase 2 trial, is listed as terminated25, with 8 enrolled. A third registered study tested a topical form on the cosmetic appearance of oily skin and is listed as completed26, with 14 people enrolled. A 2025 review adds that in some studies it has also shown beneficial effects in scar remodelling and sebum regulation13, sebum being the skin's natural oil. A registry entry records that a trial happened and how big it was, which is not the same as what it found. How the blepharospasm pilot came out is on the Argireline benefits page.

Does Argireline work any other way than relaxing muscle?

in vitro

Some laboratory work suggests a second, slower route, through collagen, the protein that keeps skin firm. A 2025 study of a delivery system built around the peptide says the system repairs static wrinkles by promoting collagen production27, static wrinkles being the lines that stay when the face is still. In the same skin-spheroid model that showed its effect on nerve signalling, the peptide stimulated type I collagen synthesis10. This route would not depend on reaching a muscle, only on reaching the collagen-producing cells within the skin. It does still depend on getting into the skin at all, which is the difficulty described above, so it does not get around the delivery problem so much as move it. The collagen findings in mice and in human skin cells, and what each one measured, are on the Argireline benefits page.

Is Argireline safe?

animal model

The record shows few problems, and it is a short record. The human trials that reported on harm recorded few problems, in small groups followed for weeks. The 2002 paper that introduced the peptide reported it did not exhibit in vivo oral toxicity nor primary irritation at high doses1, tested in animals by its developers. The clearest caution comes from a review of cosmetic ingredients rather than from any trial. A 2025 cosmetic safety panel concluded the available data are insufficient to judge the ingredient at concentrations greater than 0.005%3. Daily use, what it should not be mixed with, an infection after injection, and who was left out of the studies are taken apart on the Argireline safety page.

Is Argireline legal, and is it regulated as a drug?

primary research

It is sold openly as a cosmetic ingredient, and it is not an approved drug for wrinkles, for eyelid spasm or for anything else. The 2024 search-trend analysis lists affordability, over-the-counter availability, and ease of self-application of the agent among the reasons for its appeal4. Its regulatory footprint is that of a cosmetic. The only formal safety judgement on it among these sources is the cosmetic ingredient panel described above, and that judgement covers products applied to the skin, not injections or threads. The eyelid-spasm work, the one attempt to take it toward a medical use, stopped at a pilot trial and a terminated registered study. We could find no FDA recall or enforcement action naming the peptide. For a reader, the practical meaning is that a jar labelled with it has met cosmetic rules, which say nothing about whether it relaxes a wrinkle.

Why do Argireline results disagree?

human RCT

Four things change from study to study, and each can move the result. The first is the carrier: as above, a plain cream delivers far less than an engineered emulsion or a microneedle patch. The second is what else is in the jar. A 2026 study tested a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate, gluconolactone, niacinamide and laminaria extract28, so a good result from it belongs to the whole mix. The third is the state of the peptide itself. A 2021 analysis of retail creams and serums found argireline and its oxidized form in several different cosmetics23, with the weak point being the methionine in its sequence23. The fourth is how wrinkles were measured. The 2013 trial made silicone replicas of the skin before and after treatment2, while the 2023 split-face study used camera analysis and found a decrease that was not significant22. A positive result from a five-ingredient serum and a null result from a one-variable split-face test are not measuring the same thing, and neither cancels the other.